Janice Dickinson to Attend Ninth Annual Stem Cell World Summit with Blue Horizon International

By: PRLog
Janice Dickinson Expected to Join Dr. Brian Mehling, Founder of Blue Horizon International, at Event to Discuss Stem Cell Treatments, Special Skin Serum.
PRLog - Dec. 4, 2013 - SAN DIEGO -- Blue Horizon International (BHI), announced today its attendance at the Ninth Annual World Stem Cell Summit in San Diego.  The summit is expected to draw more than 1,200 attendees from 40 nations.  Among those in attendance will be researchers, industry leaders, advocates, clinicians, hospital administrators, philanthropists, economic development officers and at least one supermodel.

Janice Dickinson, a pioneer in the modeling industry who was injured in an accident last July, has been an outspoken advocate of stem cell therapy ever since undergoing treatments in September.

“Blue Horizon’s stem cell treatments are absolutely amazing,” said Dickinson.  "I feel great."

Dr. Brian Mehling, founder of BHI, is expected to talk about treatment options for those interested in stem cell technology and about his company’s latest product, Special Skin Serum.

"Interest from people who attend these summits has been overwhelming,” said Mehling.  “Everyone wants to learn more about the use of stem cells."

The three-day event has been scheduled to begin today.

BHI is a health care consulting company committed to providing quality care to patients, cutting-edge stem cell therapies to emerging markets, and medical resources to the underserved.  Its subsidiaries have safely and efficiently performed and documented over 2000 stem cell therapy procedures worldwide.  For more information visit www.bluehorizonstemcells.com.

Read Full Story - Janice Dickinson to Attend Ninth Annual Stem Cell World Summit with Blue Horizon International | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.